Very late thrombosis of a drug-eluting stent deployed during primary angioplasty for ST-elevation myocardial infarction.
Drug-eluting stents, despite being very effective in reducing restenosis after percutaneous coronary interventions, are associated with a low but definite risk of late thrombotic occlusion with adverse clinical events. To date, the incidence and overall risk of late thrombosis of drug-eluting stents after primary percutaneous coronary interventions for ST-elevation myocardial infarction are not well defined because of the relative paucity of evidence-based data. We report the case of an angiographically confirmed paclitaxel-eluting stent thrombosis, occurring 20 months after successful primary percutaneous coronary intervention in a 41-year-old woman. To the best of our knowledge, this is the most delayed case of paclitaxel-eluting stent thrombosis described so far.
Rigattieri
Stefano
S
Cardiology Department, Sandro Pertini Hospital, ASL Roma B, Rome, Italy. stefanorigattieri@yahoo.it
Patrizi
Roberto
R
Silvestri
Pasquale
P
Di Russo
Cristian
C
Musto
Carmine
C
Ferraiuolo
Giuseppe
G
Palamara
Antonio
A
Loschiavo
Paolo
P
D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000379:methods; D006328:Cardiac Catheterization; D017023:Coronary Angiography; D003328:Coronary Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D017239:Paclitaxel / Q000008:administration & dosage; D019233:Retreatment; D018570:Risk Assessment; D017131:Thrombectomy / Q000379:methods; D013997:Time Factors
D017239:Paclitaxel